Joint Diseases  >>  prezalumab (AMG 557)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
prezalumab (AMG 557) / Amgen, AstraZeneca
NCT01683695: Safety Study of AMG 557 in Subjects With Lupus Arthritis

Checkmark Top-line results in SLE and lupus related inflammatory arthritis
Mar 2018 - Mar 2018: Top-line results in SLE and lupus related inflammatory arthritis
Completed
1
20
US, Europe, RoW
AMG 557, Matching Placebo
Amgen
Lupus Arthritis, Systemic Lupus Erythematosus
03/16
03/16

Download Options